Sweden's Orexo has announced it has bought the exclusive US rights to GAIA’s deprexis, a digital therapy to help patients manage their symptoms of depression and one of the most researched
As the number of coronavirus cases in the world exceeds 1.4 million, the pharma industry is pushing to find new drugs, therapies and tests in the effort to bring the pandemic under control.
A mental health app for young people has seen a spike of 168% during the COVID-19 coronavirus outbreak – and as a result of the increased demand is now freely available to young people acro
In the age of smartphones and virtual reality, NHS trusts must evolve their approach to reach patients, and can look towards a future of clinically proven personalised digital therapeutic t
An algorithm could be used by an NHS hospital in England to predict which people may experience a mental health crisis based on their mobile phone use, according to a press report.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.